跳至主要内容
临床试验/RBR-7tdjcn5
RBR-7tdjcn5进行中(未招募)Unknown

Efficacy and safety of using Botulinum Toxin type A in the Masseter Hypertrophy treatment

Faculdade Ingá - UNINGÁ/Paraná0 个研究点开始时间: 2024年1月24日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25Y 至 50Y(—)
性别
Female

入选标准

  • Female patients; age between 25 and 50 years; complaining of enlargement of the lower third of the face; complaining of unilateral or bilateral hypertrophy of the masseter muscle; have not received aesthetic procedures on the lower third of the face in the last 12 months

排除标准

  • Having received an anti-tetanus or COVID-19 vaccine within a period of less than three months, before starting the research; having previously received injections of botulinum toxin for aesthetic or therapeutic purposes; presenting autoimmune diseases; pregnant and lactating women; present neuromuscular diseases (Myasthenia gravis and Lambert-Eaton Syndrome); in current use of drugs that act on neuromuscular junctions; having performed cosmetic surgeries on the lower third of the face; missing teeth; individuals under 25 years of age; those who do not agree to sign the Free and Informed Consent Form; those who receive some type of vaccine during the research; received aesthetic procedures in the lower third of the face in the last 12 months

研究者

发起方
Faculdade Ingá - UNINGÁ/Paraná

相似试验